Shrawan Patel, MD’s Post

The expression “Last but not Least” was never more true than when the startups in PharmStars' current cohort were joined last week by Mark T. Rutledge, PhD of Sumitomo Pharma America, Inc. (SMPA) for the final Fireside Chat of our Spring semester. Mark visited our PharmaU program to engage our startups in a discussion about opportunities for digital health innovation at SMPA. At SMPA (as with many pharma), the landscape for digital health innovation continues to evolve. Mark helped the startups understand how both internal and external forces are influencing change and the impact change is having on SMPA's appetite for innovation. Though market conditions are dictating the need for heightened scrutiny on projects, Mark emphasized SMPA’s continues to focus on opportunities that will deliver value, save money, and help get therapies to the market quickly and to the patients who will benefit from them. SMPA is currently developing their promising oncology assets, which is a perfect fit with PharmStars' current cohort of startups focused on "Digital Innovations in Oncology." We are excited for Mark and his colleagues to meet our startups next month at our culminating Showcase Event where they will share their innovations with SMPA and our other pharma members. Thanks, Mark, for sharing your insights, wisdom and enthusiasm with our Spring cohort of startups. We value your time and your partnership! #Startup #Accelerator #DigitalHealth #pharma #biopharma #innovation #acceleratorprogram #biopharma

Discover three of the most interesting #HealthTech startups in Italy!🏆 Week four of our "Top Three Italian Startups" format, in which Arcadia showcases interesting startups working in the most strategic and impactful sectors. Today it's the turn of Health Tech, so here are three of the most promising Italian startups that are fighting to make healthcare closer to what it should be:👇🏻 Patchai, an Alira Health Company is a Milanese startup founded in 2018 that has dedicated itself to developing an intelligent platform for managing patients and their data in real time, in order to make clinical research and the necessary clinical practices more tolerable and less invasive for patients. So much so that the US company Alira Health acquired them.🖥️ We remain in Milan, where there is also Dianax S.r.l, active since 2013 to enhance the efficiency and value of healthcare by bringing screening, diagnosis and disease monitoring closer to the patient. How? With comfortable, inexpensive and easy-to-use microfluidic lab-on-a-chip devices directly at the Point of Need Testing.🩺 Finally, we stay in Milan (not on purpose), where in 2016 Enthera Pharmaceuticals was born, a startup that creates innovative therapies for diabetes and other gastrointestinal diseases. Enthera changes the paradigm of care, focusing on the interaction between the TMEM219 receptor and its ligand IGFBP3, which allows for effective and safe treatments that were previously difficult to achieve.😷 Follow Arcadia to discover other top three #startups!

📣 Are you a Swiss early-stage startup or a pre-startup (planning to be incorporated soon) tackling problems related to oncology, pain treatment, or AI for health and drug development? 🌐   Then take advantage of this unique opportunity! Whether you're an emerging science-based startup or your innovation project is still in a pre-startup phase, this is your chance to shine. 🌟   Applications are now open for Swiss early-stage startups (max 3 years after incorporation) and pre-startups that aim to turn science into health solutions focusing on oncology, pain treatment, or AI for health and drug development. Swissnex and the Embassy of Switzerland in Denmark have partnered with #YScience, the official side event of Slush for Life Sciences, organized by the Helsinki Institute of Life Science (HiLIFE) at the University of Helsinki in collaboration with Orion Corporation.   🏆 The finalists will receive pitching coaching, get a Startup Pass to attend Slush, pitch in the Y Science stage and in the #Swisstech Pavilion at Slush, meet potential investors, network with experts in the fields of their solution – and compete for the 5000 EUR prize for the winner!   ➡ Apply until 23 September and check more info here:  https://lnkd.in/e_J297JF   #Startup #Innovation #OpenCall #PitchingCompetition #Pharma #PainTreatment #AIforHealth #DrugDevelopment #Startups #Slush

🙋♀️ Do you believe in the promise of #DigitalHealth to improve #patient outcomes and #reducecost in #drugdevelopment and #caredelivery? 💊 📲 Do you want to know how to bridge the gap between #pharma and digital #health #startups working on these innovative solutions? 💥 PharmStars knows how to bring startups and #biopharma together to bridge that gap! Our 10-week #accelerator program is designed to prepare startups for more productive engagements with pharma, teaching them what they need to know. 🚀 🌏 PharmStars is a virtual #accelerator, open to digital health startups from around the world because healthcare #innovation has no bounds 🙌 and happens anywhere. Our Spring accelerator will focus on "Digital Innovations in #Oncology." Learn more and apply (deadline is February 1!) 👉 👉 👉  www.PharmStars.com for details and to apply

📣 Are you a Swiss early-stage startup or a pre-startup (planning to be incorporated soon) tackling problems related to oncology, pain treatment, or AI for health and drug development? 🌐 Then take advantage of this unique opportunity! Whether you're an emerging science-based startup or your innovation project is still in a pre-startup phase, this is your chance to shine. 🌟 Applications are now open for Swiss early-stage startups (max 3 years after incorporation) and pre-startups that aim to turn science into health solutions focusing on oncology, pain treatment, or AI for health and drug development. Swissnex and the Embassy of Switzerland in Denmark have partnered with #YScience, the official side event of Slush for Life Sciences, organised by the Helsinki Institute of Life Science (HiLIFE) at the University of Helsinki in collaboration with Orion Corporation. 🏆 The finalists will receive pitching coaching, get a Startup Pass to attend Slush, pitch in the Y Science stage and in the #Swisstech Pavilion at Slush, meet potential investors, network with experts in the fields of their solution – and compete for the 5000 EUR prize for the winner! ➡ Apply until 23 September and check more info here: https://lnkd.in/e_J297JF #Opencall #PitchingCompetition #Pharma #PainTreatment #AIforHealth #DrugDevelopment #Startups #Slush #SwissStartup

We are getting there! Thanks for the mention, Zefyron. Humbling and exciting to see that 1) Health in general is getting more and more prime time attention ⭕ 2) #longevityNOW interventions like ours at Luminous Labs are now getting the spotlight and bigger masses are beginning to understand what it needs in healthspan and lifespan enhancement to succeed. ⭕ . As Sergey Young says, there are four horizons in longevity: diagnostics, prevention, intervention and reversal. . So far, longevity is mainly seen as moonshots; hardcore biotechs and reversal actions that should make us live forever, maybe. Now this is changing and that is GREAT, and it is an honour for us at Luminous Labs to really be seen for what we do. . We are biotech at core, but in a way that already enables humans to experiment and experience our technology in the now; non-invasive, low risk and with so much more potential to explore. 🚀 . Solving mitochondrial dysfunction one step at a time. 🧬 Thanks for the support BIOGENA GROUP Science Park Graz (SPG) Steirische Wirtschaftsförderung SFG FFG Austrian Research Promotion Agency And to all the ones that are on the journey with us BEYOND GENOMiX Maximon - The Longevity Company Builder Longevity Investors and many many more

🎤 Today, we have the pleasure of featuring Dr Kieran Mulroney, CEO and founder of Cytophenix (CUREator Health Security Stream) and his team.   🚀 The Cytophenix Mission: We spun out of The University of Western Australia in 2023 with a clear mission—to help doctors get the right antibiotic to the right patient faster while preserving the most potent antibiotics for future use. Our diagnostic test improves individual patient outcomes and supports global antimicrobial stewardship, an increasingly urgent need in the face of antimicrobial resistance (AMR).   💡 What Inspired Cytophenix: Our tech came from academic insights, where we saw the potential to drastically improve clinical decision-making by speeding up the process of getting doctors the information they need. With AMR making treatment decisions harder, getting the right test results faster is essential.   🎯 Why We Applied For CUREator: Our technology was at a critical stage of development. We needed to refine our Artificial Intelligence (AI) software, automate analysis, and test an end-to-end prototype. The CUREator program came at just the right time, helping us field-test our product, develop regulatory strategies, and set the foundation for market entry.   📈 How We've Grown: The CUREator program helped us spin out of UWA and really accelerate our commercialisation efforts. With follow-on funding and further support from programs like CSIRO ON, we’re preparing for regulatory approval and engaging investors as we move toward our next big milestones.   💬 Advice for Biotech Startups: Joining an incubator like CUREator is just the start. Keep testing your ideas, talking to stakeholders, and evolving as you go. And remember—it takes a village to build something meaningful.   Congratulations to the talented Cytophenix team! Christine Carson Sherief Khorshid Teagan Paton Nick Thomson #CUREator #HealthSecurity #Biotech #Innovation #AntimicrobialResistance #Healthcare #Startups #Cytophenix #PatientCare

*. startups acceleration in Switzerland.* DayOne Health 4.0 is now accepting applications 📣 What is this program all about? DayOne Health 4.0 is our six-month hybrid acceleration program led by Cécile Tardy-Srinivasan and supporting health tech startups, from Seed to Series A stage. Our 2024 edition is focused on AI, data, and digitally enhanced clinical development. We welcome startups innovating across clinical trials, from novel biomarkers (digital, imaging) to patient engagement in DCT and beyond. Whether you're tackling challenges from the tech, clinician and/or patient side, if you're driving solutions transforming clinical development, we want to hear from you! 🌍 Global Cohort: Join a diverse cohort of 15 startups and get to know them during the kick-off bootcamp in Basel. 📅 Program duration: September 2024 - March 2025 💡 From Prototype to Paying Users: Open to startups at various maturity stages and whether or not you're currently raising funds. 📝 Application Deadline: 15 June #InnovateInBasel #DayOne #ShapingtheFutureofHealth #innovation

📈💡Austrian Biotech Innovators With Austria’s biotech ecosystem continually evolving, its contribution to global healthcare is set to grow exponentially. From breakthrough therapies to cutting-edge diagnostics, early-stage startups are pushing the boundaries of what’s possible. Backed by a robust ecosystem of academia, government, and industry collaboration, these innovators are setting the stage for the next big leap in healthcare. But it’s not just about invention—it’s about impact. These startups are tackling some of the world’s most pressing health challenges, striving to cut costs, improve patient outcomes, and expand treatment access on a global scale. 🔗 Read more about the Top 10 Early-Stage Life Sciences/Biotech Startups reshaping the future: https://lnkd.in/gF4pibuy ✨ Featured Startups: ◾ Sarcura – Daniela Buchmayr, Erwin Gorjup (Cell therapy manufacturing) ◾ HeartBeat.bio AG – Michael Krebs, Florian Fuchs (Cardiac drug discovery) ◾ a:head bio AG – Oliver Szolar, Madeline Lancaster (CNS drug discovery) ◾ VALANX Biotech – Michael Lukesch (Protein conjugation) ◾ Cellectric Biosciences – Terje Wimberger, Klemens Wassermann(Precision diagnostics) ◾ Biolyz – Marlon Millard (Non-invasive analytics) ◾ Solgate – Ariel Bensimon, Giulio Superti-Furga, Stefan Kubicek, and Georg Winter (Metabolic disease targeting) ◾ HD Immune – Stefan Bartl, Lionel Wightman (Huntington’s treatment) ◾ Phoenestra GmbH – Klaus Graumann(Cell therapy bioprocessing) ◾ Luminous Labs – Barbara Sekulovska, Thomas Lechner (Red light therapy) ✨ Key Investors Supporting BioTech Innovation: XYZ Ventures | xista science ventures | Nina Capital |CTI Life Sciences Fund | Tensor Ventures | Atrinum. Ventures AG | Austria Wirtschaftsservice | Austrian Angel Investor Association (aaia) 🔍 Explore more such startups on Zefyron's Startup and Investor Database : bit.ly/Zefyron 🆓 Sign up for FREE: bit.ly/ZefyronFree #BiotechInnovation #LifeSciences #Healthcare #AustrianStartups

#Founders, get ready for an unfiltered look at the world of startups at Healthcare Truth, Triumphs and Trials! Join us for Founder Truths: Navigating Startup Challenges. Our esteemed panellists will share their unvarnished personal and business journeys, offering actionable insights for aspiring entrepreneurs in the healthcare sector. Meet the Visionaries: Amit Goldman: Venture Fellow Leader for DigitalDx Ventures and Head of Partnerships for Lapsi Health, Amit is a visionary leader committed to transforming the HealthTech landscape. Mike Karim, CEO and Co-founder of Oxford Endovascular Ltd. Mike brings over 30 years of experience in medical technology to the table. He leads Oxford Endovascular in developing a ground breaking device for treating life-threatening brain aneurysms. Jenny Barnett Dr. Jenny Barnett, CEO of Monument Therapeutics. A scientific powerhouse with an impressive track record, Jenny spun out Monument Therapeutics from Cambridge Cognition. This innovative company focuses on the development of novel treatments. Sheila Kissane, CEO of Boutros Bear. A remarkable transformation from civil engineer to healthcare entrepreneur, Sheila's personal battle with cancer fuelled her passion to create Boutros Bear. Her company delivers comprehensive rehabilitation programs, empowering individuals facing cancer, chronic pain, and mental health challenges. Get on the waitlist https://lnkd.in/eX6aK75j Don't miss this opportunity to learn from these inspiring leaders and embark on your own healthcare journey! #Community #ThankYou #Healthcare #healthtech #medtech #lifesciences #biotech #techbio #digitaltherapeutics #diagnostics #therapeutics #digitalhealth #founderjourney #venturecapital